Company Pivotal Therapeutics Inc. Other OTC
Equities
PVTTF
CA72582E1043
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Omega-3 Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -5.76% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
99.2
%
| 0 | 97.2 % | 0 | 99.2 % | -3.83% |
Canada
0.8
%
| 0 | 2.8 % | 0 | 0.8 % | -74.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 10-09-30 | |
George Jackowski
FOU | Founder | - | 10-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Jackowski
FOU | Founder | - | 10-09-30 |
John Gebhardt
CHM | Chairman | 77 | 11-11-21 |
Founder | - | 10-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,566,669 | 96,566,669 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Pivotal Therapeutics, Inc.
30 Pennsylvania Avenue Unit 17
L4K 4A5, Concord
+
http://www.pivotaltherapeutics.us![address Pivotal Therapeutics Inc.(PVTTF)](https://cdn.zonebourse.com/static/address/10156572.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.37% | 43.39B | |
+19.44% | 22.01B | |
+17.85% | 15.46B | |
+25.55% | 14.93B | |
+60.99% | 13.13B | |
-0.05% | 6.79B | |
-15.02% | 6.36B | |
-8.87% | 5.73B | |
+8.17% | 5.43B |